Gilles Nobécourt

Gilles joined Andera Partners in 2002.

During his thirteen years in the biotechnology and pharmaceutical industries, Gilles held positions in the major industry segments: discovery, product development, clinical development, manufacturing, marketing, sales and business development.

He has extensive experience in negotiations, management of alliances and comprehensive operational management experience on a worldwide basis (Europe, US, Japan, Latin America).

He sits on several boards including GenKyoTex, Complix, Inotrem, Complexa and Crescendo Biologics. He was also a board member of U3 Pharma, Covagen and Glycovaxyn until their acquisition by large pharmaceutical companies.

Gilles graduated from Institut d’Etudes Politiques de Paris in 1980, received a Master’s in Applied Economics in 1982 and followed further business training at the Stanford Graduate School of Business.